Skip to main content

Table 2. Conditioning regimen for haplo-SCT

From: Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

  1. TBF thiotepa–busulfan–fludarabine, TREO treosulfan, FLU fludarabine, TBI total body irradiation, Cy cyclophosphamide, BU busulfan, MEL melphalan, THIO thiotepa, PT-Cy post-transplant cyclophosphamide, FK506 tacrolimus, MMF micophenolate mofetil, Rapa rapamycin, ATG antithymocyte globulin, CSA cyclosporine
  2. *Sequential regimen of chemotherapy
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us